Home Cart 0 Sign in  
X

[ CAS No. 915087-25-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 915087-25-1
Chemical Structure| 915087-25-1
Chemical Structure| 915087-25-1
Structure of 915087-25-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 915087-25-1 ]

Related Doc. of [ 915087-25-1 ]

Alternatived Products of [ 915087-25-1 ]

Product Details of [ 915087-25-1 ]

CAS No. :915087-25-1 MDL No. :MFCD09909322
Formula : C8H9FN2O Boiling Point : -
Linear Structure Formula :- InChI Key :XOKAXPQJUODMSH-UHFFFAOYSA-N
M.W : 168.17 Pubchem ID :44139521
Synonyms :

Calculated chemistry of [ 915087-25-1 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 43.8
TPSA : 55.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.59 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.08
Log Po/w (XLOGP3) : 1.04
Log Po/w (WLOGP) : 1.2
Log Po/w (MLOGP) : 1.34
Log Po/w (SILICOS-IT) : 1.08
Consensus Log Po/w : 1.15

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.78
Solubility : 2.82 mg/ml ; 0.0168 mol/l
Class : Very soluble
Log S (Ali) : -1.79
Solubility : 2.74 mg/ml ; 0.0163 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.7
Solubility : 0.337 mg/ml ; 0.002 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.13

Safety of [ 915087-25-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 915087-25-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 915087-25-1 ]
  • Downstream synthetic route of [ 915087-25-1 ]

[ 915087-25-1 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 956104-46-4 ]
  • [ 915087-25-1 ]
YieldReaction ConditionsOperation in experiment
100% With trifluoroacetic acid In dichloromethane at 20℃; Methyl 4-amino-2-fluoro-benzylamide <n="55"/>[0087] TFA (1 niL) is added dropwise to a solution of methylamide (60 mg, 0.21 mmol) in dry DCM (0.5 mL) under argon. The solution is stirred overnight at room temperature. After completion of the reaction, the solvent is evaporated and the residue is purified by flash chromatography on silica gel (Hexane/EtOac) to afford the desired product quantitatively.[0088] 1H NMR (500 MHz CDC13) δ 2.98 (d, J = 4.8 Hz, 3H), 4.15 (br s, 2H), 6.32(d, J = 14.3 Hz, IH), 6.48 (d, J = 8.2 Hz, IH), 6.61 (br s, IH), 7.90 (dd, J = 8.6 Hz, IH), 13C NMR (500 MHz CDC13) δ 26.63, 100.8 (d, J = 28.8 Hz), 110.3 (d, J = 244.6 Hz), 110.9, 133.3 (d, J = 4.3 Hz), 151.4 (d, J = 12.5 Hz), 162.2 (d, J = 244.6 Hz),164.3 (d, J = 3.5 Hz).
95% With trifluoroacetic acid In dichloromethane A solution of 2,4-difluoro-benzoylchloride D in a solution of methylamine and tetrahydrofuran (THF) is allowed to react to produce 2,4-difluoro-N-methylbenzamide M (quantitative yield). The 2,4-difluoro-N-methylbenzamide M is mixed with in a solution of acetonitrile and 4-methoxy-benzenemethanamine and heated in a microwave for 20 minutes at 190° C. to produce 2-fluoro-4-(4-methoxybenzylamino)-N-methylbenzamide S (yield of 40percent). The 2-fluoro-4-(4-methoxybenzylamino)-N-methylbenzamide S is reacted in a solution of dichloromethane and trifluoroacetic acid to produce 2-fluoro-4-amino-N-methylbenzamide T (yield greater than 95percent). The 2-fluoro-4-amino-N-methylbenzamide T is reacted with a solution of sodium cyanide and cyclobutanone to produce 4-(1-cyanocyclobutylamino)-2-fluoro-N-methylbenzamide B.
Reference: [1] Patent: WO2008/119015, 2008, A2, . Location in patent: Page/Page column 52-53
[2] Patent: US9388159, 2016, B2, . Location in patent: Page/Page column 21; 22
  • 2
  • [ 915087-24-0 ]
  • [ 915087-25-1 ]
YieldReaction ConditionsOperation in experiment
97% With acetic acid In ethyl acetateReflux Synthesis of 4-Amino-2-fluoro-N-methyl-benzamide 4a. [00194] To a solution of 2-fluoro-N-methyl-4-nitro-benzamide 21 (3g, 15.1mmol) in co-solvent of ethyl acetate and acetic acid (12mL+12mL) was added iron dust (8g, 143.mmol). The suspension was heated at reflux until the starting material disappeared in LCMS. Cooled down to 25°C. The solid was filtered off and the filtrate was diluted with ethyl acetate (50mL). The organic phase was washed with brine (3x30mL), dried (MgS04) and concentrated to dryness in vacuo. The title compound 4a was obtained as an orange solid (2.5g, 97percent yield). MS: 169 (M+H)+. 1H NMR (acetone-d6, 500MHz): δ 7.69 (1H, dd, J=8.7, 8.8Hz), 7.15 (1H, s), 6.51 (1H, dd, J=8.6, 2.1Hz), 6.38 (1H, dd, J=14.7, 2.1Hz), 5.70 (1H, br s), 2.88 (3H, d, J=4.3Hz).
92% With iron; acetic acid In ethyl acetate for 1 h; Heating / reflux A mixture of N-methyl-2-fluoro-4-nitrobenzamide (52a) (2.89 g, 14.6 mmol) and iron(5.04 g, 90 mmol) in ethyl acetate (40 ml) and acetic acid (40 ml) was refluxed for 1 hour. The solid particles were filtered off. The filtrate was washed with water and extracted with ethyl acetate. The organic layer was dried over MgSO4, concentrated and chromatographed (dichloromethane:acetone,95:5) to yield N-methyl-2-fluoro-4-aminobenzamide (52b) (2.3 g, 13.7 mmol, 94percent) as an off-white solid..H ΝMR (acetone-d 400 MHz) δ 2.86 (d, J= 4.3 Hz, 3H), 5.50 (bs, 2H), 6.37 (dd, J&1 = 14.7 Hz, J2 = 2.1Hz, IH), 6.50 (dd, J= 8.5, 2.1 Hz, IH), 7.06 (bs, IH), 7.68 (dd, J= 8.8 8.8 Hz, IH); 13C ΝMR (acetone- d6, 100 MHz) δ 25.8, 99.6 (d, J= 13.8 Hz), 109.2 (d, J= 12.8 Hz), 110.0 (d, J= 1.6 Hz), 132.5 (d, J= 4.8Hz), 153.5 (d, J= 12.6 Hz), 162.2 (d, J= 242.5 Hz), 164.0 (d, J= 3.1 Hz).; A mixture of N-Methyl-2-fluoro-4-nitrobenzamide (Formula 38) (0.18 g, 0.91 mmol) and iron (0.31 g, 5.60 mmol) in ethyl acetate (5 mL) and acetic acid (5 mL) was refluxed for 1 h. The solid particles were filtered off. The filtrate was washed with water and extracted with ethyl acetate. The organic layer was dried over MgSO4, concentrated and the residue was purified with SiO2 column chromatography (dichloromethane:acetone, 95:5) to give N-Methyl-2-fluoro-4-aminobenzamide (Formula 39) (0.14 g, 92percent) as an off-white solid. 1H ΝMR (acetone-^) δ 2.86 (d, 3 H, J=4.3), 5.50 (br s, 2 H), 6.37 (dd, 1 H, /=14.7 and 2.1), 6.50 (dd, IH, J=8.6 and 2.1), 7.06 (br s, IH), 7.68 (dd, IH, J=8.8 and 8.8).
92% With iron; acetic acid In ethyl acetate for 1 h; Heating / reflux A mixture of N-Methyl-2-fluoro-4-nitrobenzamide (Formula 38) (0.18 g, 0.91 mmol) and iron (0.31 g, 5.60 mmol) in ethyl acetate (5 mL) and acetic acid (5 mL) was refluxed for 1 h.
The solid particles were filtered off.
The filtrate washed with water and extracted with ethyl acetate.
The organic layer was dried over MgSO4, concentrated and the residue was purified with SiO2 column chromatography (dichloromethane:acetone, 95:5) to give N-Methyl-2-fluoro-4-aminobenzamide (Formula 39) (0.14 g, 92percent) as an off-white solid. 1H NMR (acetone-d6) δ 2.86 (d, 3H, J=4.3), 5.50 (br s, 2H), 6.37 (dd, 1H, J=14.7 and 2.1), 6.50 (dd, 1H, J=8.6 and 2.1), 7.06 (br s, 1H), 7.68 (dd, 1H, J=8.8 and 8.8).
83.3% With hydrogen; acetic acid In methanol at 20℃; Autoclave Charge 100g of 2-Fluoro-N-methyl-4-nitrobenzamide and 500ml of methanol into the 1L autoclave at ambient temperature. To this add, 35 ml of Encapsulated Raney Ni (previously washed with water) and 3g of acetic acid. Close the autoclave and flush with nitrogen for 2 times and then pressurized with hydrogen to 5.0 Kg and maintain until completion of the reaction. After completion of the reaction filter the catalyst and wash with 50 ml of methanol. Concentrate the filtrate to remove the methanol under vacuum at 45-50°C to a thick residue and add 300 ml of water, stir slurry for lh and filter, wash with 50 ml of water. Dry the product and dry wt is 70g (83.3percent).
62% With iron; acetic acid In ethyl acetate for 16 h; Inert atmosphere; Reflux To a solution of compound 7 (14.6g, 73.7mmol) in EA (100ml) and AcOH (9.2ml, 0.50mol) was added Fe (39g) portion-wise under N2 at room temperature. The reaction mixture was refluxed for 16h. After cooling to room temperature, the reaction mixture was filter, then, the filtrate was concentrated under reduced pressure. The residue was purified by flash column chromatography on silics gel (ethyl acetate/ petroleum ether=1/1) to afford 4-amino-2-fluoro-N-methylbenzamide (9) (7.6g, 62percent). 1H NMR (400 MHz, CDCl3) δ 7.92 (t, J=8.8 Hz, 1H)6.60 (s, 1H)6.49 (d, J=8.4 Hz, 1H), 6.32 (d, J=14Hz, 1H), 4.10 (s, 2H), 2.99 (d, J=4.4Hz, 3H). MS (ESI): m/z 169.1 (M+H+, positive mode).
61.5% With iron; acetic acid In ethyl acetate for 16 h; Reflux Synthesis of 2-fluoro-N-methyl-4-amino-benzamide (Compound 5)
Compound 4 (14.6 g, 73.7 mmol) was dissolved in a solution of ethyl acetate and acetic acid (50 mL +50 mL).
Then 39 g of iron powder was added.
The resulting mixture was refluxed overnight (16 h), then cooled to room temperature.
The solid was filtered and washed with ethyl acetate for three times (3 * 50 mL).
The organic phases were combined, washed with brine, dried over sodium sulfate and concentrated to give a yellow solid which was purified by column chromatography (DCM: MeOH = 50:1), to give a pale yellow solid , compound 5 (7.62 g, yield 61.5percent).
61.5% With iron; acetic acid In ethyl acetate for 16 h; Reflux Compound 7 (14.6 g, 73.7 mmol) was dissolved in a solution of ethyl acetate and acetic acid (50 ml: 50 ml). Iron powder (39 g) was added. The resulting mixture was refluxed overnight for 16 h, and then cooled to room temperature. The solid was filtered and washed three times with ethyl acetate (3x50 ml). The combined organic phases were washed with brine, dried over sodium sulfate and concentrated the residue was purified by column chromatography (DCM:MeOH=50:1)to give a pale yellow solid of compound 8 (7.62 g, 61.5percent yield). ‘H NMR (CDC13, 400 MHz): ö 7.92 (1H, m), 6.60 (1H, s), 6.49 (1H, d, J=8.4 Hz), 6.32 (1H, d, J=14 Hz), 4.10 (2H, s), 2.99 (3H, s) ppm.
10.5 g With palladium 10% on activated carbon; hydrogen In methanol at 27℃; N-Methyl 2-flouro-4-nitro benzamide (Formula VI; 13 g) was added to methanol(260 mL) followed by the addition of 10percent (w/w) palladium/carbon (1.3 g) at 27°C andhydrogen gas at 2 Kg/cm2 to 2.5 Kg/cm2 pressure for 2 hours to 4 hours. The reaction mixture was filtered through celite and washed with methanol (40 mL). The solution obtained was concentrated under reduced pressure at 30°C to 35°C for 1 hour to 2 hours to obtain the title compound.Yield: 10.5 g.

Reference: [1] Patent: WO2011/29392, 2011, A1, . Location in patent: Page/Page column 62-63
[2] Journal of Medicinal Chemistry, 2010, vol. 53, # 7, p. 2779 - 2796
[3] Patent: WO2006/124118, 2006, A1, . Location in patent: Page/Page column 73; 78-79
[4] Patent: US2007/254933, 2007, A1, . Location in patent: Page/Page column 6-7
[5] Patent: WO2018/112001, 2018, A1, . Location in patent: Paragraph 0149
[6] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 12, p. 2803 - 2806
[7] Patent: EP2792674, 2014, A1, . Location in patent: Paragraph 0065; 0066
[8] Patent: US2016/152592, 2016, A1, . Location in patent: Paragraph 0073; 0084; 0085
[9] Patent: US2014/371284, 2014, A1, . Location in patent: Page/Page column
[10] Patent: WO2015/63720, 2015, A1, . Location in patent: Page/Page column 9; 10
[11] Patent: WO2016/38560, 2016, A1, . Location in patent: Page/Page column 7; 8
[12] Journal of Labelled Compounds and Radiopharmaceuticals, 2017, vol. 60, # 9, p. 401 - 409
  • 3
  • [ 403-24-7 ]
  • [ 915087-25-1 ]
Reference: [1] Patent: WO2011/29392, 2011, A1,
[2] Patent: EP2792674, 2014, A1,
[3] Patent: WO2015/63720, 2015, A1,
[4] Patent: WO2016/38560, 2016, A1,
[5] Patent: US2016/152592, 2016, A1,
[6] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 12, p. 2803 - 2806
[7] Journal of Labelled Compounds and Radiopharmaceuticals, 2017, vol. 60, # 9, p. 401 - 409
[8] Patent: WO2018/112001, 2018, A1,
  • 4
  • [ 74-89-5 ]
  • [ 915087-25-1 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 21, p. 5536 - 5539
  • 5
  • [ 72482-64-5 ]
  • [ 915087-25-1 ]
Reference: [1] Patent: US9388159, 2016, B2,
[2] Patent: WO2008/119015, 2008, A2,
  • 6
  • [ 948717-18-8 ]
  • [ 915087-25-1 ]
Reference: [1] Patent: US9388159, 2016, B2,
[2] Patent: WO2008/119015, 2008, A2,
  • 7
  • [ 1427-07-2 ]
  • [ 915087-25-1 ]
Reference: [1] Patent: WO2015/63720, 2015, A1,
  • 8
  • [ 915087-25-1 ]
  • [ 2052-01-9 ]
  • [ 1289942-66-0 ]
YieldReaction ConditionsOperation in experiment
12 g With triethylamine In dichloromethane at 20 - 30℃; for 15 h; Inert atmosphere In a 500 mL four necked round bottomed flask equipped with nitrogen atmosphere facility, mechanical stirrer, thermometer and an addition funnel, (10 g) 4-amino-2-fluoro-N-methylbenzamide, (16 g) bromo-isobutyric acid and 100 mL dichloromethane were added at room temperature. (25 mL) triethylamine was added and the reaction mixture was stirred for 15 hours at 20-30° C. After completion of reaction, the reaction mixture was concentrated completely UN at 40° C. 100 mL water was added and stirred for 1 hour. 7.5 mL hydrochloric acid was added and stirred for 30 min. The reaction mixture was cooled to 0-5° C. and stirred for 1 hour, filtered, washed with 25 mL water and dried to obtain 15.2 g titled compound with 94.97percent purity by HPLC In a 500 mL four necked round bottomed flask equipped with nitrogen atmosphere facility, mechanical stirrer, thermometer and an addition funnel, (15 g) 2-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)-2-methylpropanoic acid obtained in example-1 and 120 mL acetone were heated to 55 to 60° C. for 1 hour. The reaction mixture was cooled to 0 to 5° C. and the product thus obtained was filtered and dried under vacuum at 50° C. to obtain 12 g titled compound with 99.54percent purity by HPLC.
Reference: [1] Archiv der Pharmazie, 2018, vol. 351, # 11,
[2] Patent: US2015/210649, 2015, A1, . Location in patent: Paragraph 0084; 0085
[3] Patent: US2017/158643, 2017, A1, . Location in patent: Paragraph 0117
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 915087-25-1 ]

Enzalutamide Related Intermediates

Chemical Structure| 749927-69-3

[ 749927-69-3 ]

4-Bromo-2-fluoro-N-methylbenzamide

Chemical Structure| 654-70-6

[ 654-70-6 ]

4-Cyano-3-trifluoromethylaniline

Chemical Structure| 112704-79-7

[ 112704-79-7 ]

4-Bromo-2-fluorobenzoic acid

Chemical Structure| 403-24-7

[ 403-24-7 ]

2-Fluoro-4-nitrobenzoic acid

Chemical Structure| 62-57-7

[ 62-57-7 ]

2-Amino-2-methylpropanoic acid

Apalutamide Intermediates

Chemical Structure| 573762-62-6

[ 573762-62-6 ]

5-Amino-3-(trifluoromethyl)picolinonitrile

Chemical Structure| 887707-25-7

[ 887707-25-7 ]

2-Chloro-5-iodo-3-(trifluoromethyl)pyridine

Chemical Structure| 99368-67-9

[ 99368-67-9 ]

2-Chloro-5-nitro-3-(trifluoromethyl)pyridine

Chemical Structure| 99368-66-8

[ 99368-66-8 ]

5-Nitro-3-(trifluoromethyl)pyridin-2-ol

Chemical Structure| 22245-83-6

[ 22245-83-6 ]

3-(Trifluoromethyl)pyridin-2-ol

Related Functional Groups of
[ 915087-25-1 ]

Fluorinated Building Blocks

Chemical Structure| 518057-72-2

[ 518057-72-2 ]

5-Amino-2-fluorobenzamide

Similarity: 0.90

Chemical Structure| 1369948-83-3

[ 1369948-83-3 ]

3-Amino-2-fluorobenzamide

Similarity: 0.85

Chemical Structure| 85118-03-2

[ 85118-03-2 ]

2,5-Difluorobenzamide

Similarity: 0.81

Chemical Structure| 445-28-3

[ 445-28-3 ]

2-Fluorobenzamide

Similarity: 0.81

Chemical Structure| 886502-14-3

[ 886502-14-3 ]

2-Fluoro-6-methylbenzamide

Similarity: 0.81

Aryls

Chemical Structure| 518057-72-2

[ 518057-72-2 ]

5-Amino-2-fluorobenzamide

Similarity: 0.90

Chemical Structure| 1369948-83-3

[ 1369948-83-3 ]

3-Amino-2-fluorobenzamide

Similarity: 0.85

Chemical Structure| 85118-03-2

[ 85118-03-2 ]

2,5-Difluorobenzamide

Similarity: 0.81

Chemical Structure| 445-28-3

[ 445-28-3 ]

2-Fluorobenzamide

Similarity: 0.81

Chemical Structure| 886502-14-3

[ 886502-14-3 ]

2-Fluoro-6-methylbenzamide

Similarity: 0.81

Amides

Chemical Structure| 518057-72-2

[ 518057-72-2 ]

5-Amino-2-fluorobenzamide

Similarity: 0.90

Chemical Structure| 1369948-83-3

[ 1369948-83-3 ]

3-Amino-2-fluorobenzamide

Similarity: 0.85

Chemical Structure| 85118-03-2

[ 85118-03-2 ]

2,5-Difluorobenzamide

Similarity: 0.81

Chemical Structure| 445-28-3

[ 445-28-3 ]

2-Fluorobenzamide

Similarity: 0.81

Chemical Structure| 886502-14-3

[ 886502-14-3 ]

2-Fluoro-6-methylbenzamide

Similarity: 0.81

Amines

Chemical Structure| 518057-72-2

[ 518057-72-2 ]

5-Amino-2-fluorobenzamide

Similarity: 0.90

Chemical Structure| 1369948-83-3

[ 1369948-83-3 ]

3-Amino-2-fluorobenzamide

Similarity: 0.85

Chemical Structure| 85118-03-2

[ 85118-03-2 ]

2,5-Difluorobenzamide

Similarity: 0.81

Chemical Structure| 445-28-3

[ 445-28-3 ]

2-Fluorobenzamide

Similarity: 0.81

Chemical Structure| 886502-14-3

[ 886502-14-3 ]

2-Fluoro-6-methylbenzamide

Similarity: 0.81